Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Neoplasms 3 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Smoking Cessation 2 Prostatic Neoplasms 2 Communication 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Tobacco Use Cessation 1 Thyroid Neoplasms 1 Sexual Dysfunction, Physiological 1 Rectal Neoplasms 1 Patient Preference 1 Patient Acceptance of Health Care 1 Papillary Thyroid Microcarcinoma 1 Melanoma 1 Lung Cancer Screening 1 Hematologic Neoplasms 1 Health Behavior 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 Cancer Prevention 1 Cancer Pain 1 Brain Neoplasms 1 Attitude to Health 1

Interventions

Fluorouracil 155 Oxaliplatin 133 Leucovorin 124 Capecitabine 90 Irinotecan 88 Radiotherapy 63 Bevacizumab 61 Cetuximab 38 Folfox protocol 25 Panitumumab 21 Neoadjuvant Therapy 21 Surgical Procedures, Operative 19 Chemotherapy, Adjuvant 15 Radiation 13 Floxuridine 13 Erlotinib Hydrochloride 13 Early Intervention, Educational 13 IFL protocol 11 Drug Therapy 11 Proctectomy 10 Magnetic Resonance Spectroscopy 10 Counseling 10 Surveys and Questionnaires 8 Sorafenib 8 Psychiatric Rehabilitation 8 Gene Expression Profiling 8 Radiotherapy, Intensity-Modulated 7 Immunohistochemistry 7 Gemcitabine 7 Celecoxib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rectal Neoplasms × Focus Groups × Clear all

NCT02551471 2018-08-09

PELVICARE

University Hospital, Bordeaux

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡